Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Naftifine Hydrochloride Gel 2% vs Naftin® in Tinea Pedis
NCT02335255Phase 1Completed
- Start
- Jun 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of naftifine organogel (MediQuest Therapeutics) in tinea pedis (3 arms). Primary endpoint: Therapeutic cure after end of treatment. Started Jun 2014; status: completed.
02
Drugs
naftifine organogel (MediQuest Therapeutics)
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT02335255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335255.